Cite
HARVARD Citation
VanDevanter, D. et al. (2018). Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change. Pediatric pulmonology. 53 (1), pp. 43-49. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
VanDevanter, D. et al. (2018). Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change. Pediatric pulmonology. 53 (1), pp. 43-49. [Online].